Stay updated on Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision tag v3.5.4 has been added, replacing the previous v3.5.3, indicating a software release update for the page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s revision/version indicator updates from v3.5.2 to v3.5.3, reflecting a publishing or site release change without affecting the study record content.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check67 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a routine version/UI update and does not modify study details or eligibility on the page.SummaryDifference0.1%

- Check103 days agoChange DetectedSite update deployed Revision v3.4.2 and removed the funding-lapse notice and Revision v3.4.1; these are administrative changes and do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.